World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
75
Citations
35120
World Ranking
1469
National Ranking
641

Research.com Recognitions

  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

Luis Ostrosky-Zeichner is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research primarily spans the field of Medicine, with a significant focus on Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, Surgery, and Cell Biology.

The scientist's recent notable publications include:

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance (2020), published in The Lancet Infectious Diseases
  • Antifungal Susceptibility Testing: Current Approaches (2020), published in Clinical Microbiology Reviews
  • Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM (2021), published in The Lancet Infectious Diseases
  • Invasive candidiasis (2024), published in Nature Reviews Disease Primers
  • Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity (2020), published in JCI Insight

Frequent co-authors in their research include:

  • Peter G. Pappas (20 co-authored publications)
  • George R. Thompson (16 co-authored publications)
  • Oliver A. Cornely (13 co-authored publications)
  • Andrej Spec (13 co-authored publications)
  • Martin Hoenigl (12 co-authored publications)

Ostrosky-Zeichner's research has appeared regularly in several publication venues, including:

  • Open Forum Infectious Diseases (26 publications)
  • Clinical Infectious Diseases (9 publications)
  • American Journal of Infection Control (9 publications)
  • The Lancet Infectious Diseases (5 publications)
  • Infectious Disease Clinics of North America (4 publications)

Their main research topics encompass:

  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Nail Diseases and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Plant Pathogens and Fungal Diseases
  • Infection Control and Ventilation
  • COVID-19 Clinical Research Studies

Ostrosky-Zeichner has received recognition as a Fellow of the European Confederation of Medical Mycology (ECMM), an award reflecting involvement in the professional medical mycology community. Their contributions reflect a strong focus on clinical infectious diseases, antifungal therapies, and emerging challenges within fungal infection management.

Best Publications

  • Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Peter G. Pappas;Carol A. Kauffman;David R. Andes;Cornelius J. Clancy

  • Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

    Peter G. Pappas;Carol A. Kauffman;David Andes;Daniel K. Benjamin

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Invasive candidiasis

    Unknown

  • Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Peter G. Pappas;Carol A. Kauffman;David R. Andes;Cornelius J. Clancy

  • Multicenter Clinical Evaluation of the (1→3) β-D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans

    Luis Ostrosky-Zeichner;Barbara D. Alexander;Daniel H. Kett;Jose Antonio Vazquez

  • β-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

    Zekaver Odabasi;Gloria Mattiuzzi;Elihu Estey;Hagop Kantarjian

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

    Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  • Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

    Ernst-Ruediger Kuse;Ploenchan Chetchotisakd;Clovis Arns da Cunha;Markus Ruhnke

  • Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

    Peter G. Pappas;Coleman M. F. Rotstein;Robert F. Betts;Marcio Nucci

  • Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis

    Francisco M. Marty;Luis Ostrosky-Zeichner;Oliver A. Cornely;Kathleen M. Mullane

  • Combination Antifungal Therapy

    Melissa D. Johnson;Conan MacDougall;Luis Ostrosky-Zeichner;John R. Perfect

  • Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

    Luis Ostrosky-Zeichner;John H. Rex;Peter G. Pappas;Richard J. Hamill

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • An insight into the antifungal pipeline: selected new molecules and beyond.

    Luis Ostrosky-Zeichner;Arturo Casadevall;John N. Galgiani;Frank C. Odds

  • Amphotericin B: Time for a New “Gold Standard”

    Luis Ostrosky-Zeichner;Kieren A Marr;John H Rex;John H Rex;Stuart H Cohen

  • Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

    L. Ostrosky-Zeichner;C. Sable;J. Sobel;B. D. Alexander

  • T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial

    Eleftherios Mylonakis;Cornelius J. Clancy;Luis Ostrosky-Zeichner;Kevin W. Garey

  • Invasive candidiasis in the intensive care unit.

    Luis Ostrosky-Zeichner;Peter G. Pappas

  • Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole

    Madonna J. Matar;Luis Ostrosky-Zeichner;Victor L. Paetznick;Jose R. Rodriguez

  • Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (Clinical Infectious Diseases (2007) 45, (883-893))

    P. G. Pappas;C. M.F. Rotstein;R. F. Betts;M. Nucci

Frequent Co-Authors

John H. Rex
John H. Rex The University of Texas Health Science Center at Houston
Peter G. Pappas
Peter G. Pappas University of Alabama at Birmingham
Jose A. Vazquez
Jose A. Vazquez Augusta University
John R. Perfect
John R. Perfect Duke University
Oliver A. Cornely
Oliver A. Cornely University of Cologne
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
David R. Andes
David R. Andes University of Wisconsin–Madison
Ana Espinel-Ingroff
Ana Espinel-Ingroff Virginia Commonwealth University Medical Center
Dimitrios P. Kontoyiannis
Dimitrios P. Kontoyiannis The University of Texas MD Anderson Cancer Center
Carol A. Kauffman
Carol A. Kauffman University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various related fields in healthcare and research. For those interested in the administrative side of medicine, the shortest online medical billing and coding certificate programs offer a quick way to enter the healthcare industry with flexible learning options.

Many students also consider broader online healthcare programs, which provide diverse pathways such as nursing, health informatics, or public health. These programs are designed to accommodate working professionals and can complement a microbiology background.

For those interested in public health leadership, finding the best easiest mph online programs to get into can simplify the admission process while still offering quality education. A Master’s in Public Health is a valuable addition for microbiologists aiming to impact community health.

Additionally, careers like the child life specialist role combine healthcare knowledge with emotional support skills, representing an alternative pathway that benefits from a strong scientific foundation.

Best Scientists Citing Luis Ostrosky-Zeichner

Trending Scientists